J.F. Geschwind

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma

J.F. Geschwind, Riad Salem, Brian I. Carr et al. · Gastroenterology · 2004 · 352 citations · Full text

Medicine, Oncology, Radiation Oncology +10

Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention

Peter L. Pedersen, Saroj P. Mathupala, Annette Rempel et al. · Biochimica et Biophysica Acta (BBA) - Bioenergetics · 2002 · 351 citations

Life Sciences, Molecular Biology, Oncology +10

Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase

Young Hee Ko, Peter L. Pedersen, J.F. Geschwind · Cancer Letters · 2001 · 346 citations

Medicine, Biochemistry, Oncology +16

Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.

J.F. Geschwind, Young Hee Ko, Michael Torbenson et al. · PubMed · 2002 · 257 citations

Medicine, Oncology, Pharmacology +16

<scp>GIDEON</scp> (Global Investigation of therapeutic <scp>DE</scp> cisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

Riccardo Lencioni, Masatoshi Kudo, Sheng‐Long Ye et al. · International Journal of Clinical Practice · 2013 · 222 citations

Medicine, Oncology, Pharmacotherapy +17